Libourne – 23 May 2016 – Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, is pleased to announce that Mr Philippe Lavielle has been co-opted as an independent director[1].
International expert in biotechnologies
An expert in the management of innovative companies primarily specializing in biotechnologies, Philippe Lavielle has lived and worked in San Francisco for more than 10 years. A veteran of the industrial biotech sector, he spent more than 20 years with Genencor Group, one of the leading architects in industrial enzymes later acquired by DuPont, where he worked as Vice President and BU Manager before being named Executive Vice President in charge of Business Development.
From 2011 to 2014, Philippe Lavielle was appointed President and CEO of VIRDIA, a company specializing in the development of innovative industrial solutions in the production of biofuels and bioproducts, before taking up various directorships for California-based start-ups from July 2014.
56 years of age and married with three children, Philippe Lavielle holds a Masters from HEC in Paris and a diploma from the International Institute for Management Development (IMD).
Pierre Calleja, Chairman of Fermentalg's Board of Directors, said: "We are delighted to welcome Philippe Lavielle to our Board of Directors. His vast experience in the challenges that face today's industrial sectors and his global perspective will be crucial assets at a time when Fermentalg is set to enter into the commercialization of its first molecules and accelerate its deployment worldwide."
“It is with great pleasure that I'm joining the company's Board of Directors”, adds Philippe Lavielle. “with the market launch of its first product in 2016 Fermentalg is entering a decisive phase of its development, which will give us a first proof of its strong growth potential.”
Following this co-opting, Fermentalg's Board of Directors shall include:
- Pierre Calleja, Chairman
- Emertec Gestion, represented by Bernard Maitre
- Demeter Partners, represented by Stéphane Villecroze
- Bpifrance Investissement, represented by Gilles Schang
- Philippe Lavielle
- Agnès Paillard
About Fermentalg
Founded in 2009 by Pierre Calleja, Fermentalg is an industrial biotechnology company that specializes in producing sustainable oils and proteins derived from the exceptional properties of microalgae. Its patented technology allows it to target a range of fast-growing global markets, from nutrition and animal feed to cosmetics and health. Fermentalg has already signed its 1st joint-venture for the production of Omega-3 oils rich in DHA. Fermentalg shares are listed on Euronext in Paris (FR0011271600 - FALG). For more information, visit the Fermentalg website at: www.fermentalg.com.
|
Press Relations: |
Investor Relations: |
|
ACTUS finance & communication
Alexandra Prisa Tel: +33 (0)1 53 67 36 90 aprisa@actus.fr |
ACTUS finance & communication
Jérôme Fabreguettes-Leib Tel: +33 (0)1 53 67 36 78 jfl@actus.fr |
[1] The resolution to co-opt Mr Lavielle will be ratified by Fermentalg's next Annual General Meeting of shareholders.
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Communiqué intégral et original au format PDF :
https://www.actusnews.com/documents_communiques/ACTUS-0-44371-Fermentalg-CP-PLavielle-vDEF-EN.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer